首页 > 最新文献

ISRN Pharmaceutics最新文献

英文 中文
Validation of simultaneous volumetric and HPLC methods for the determination of pridinol mesylate in raw material. 体积法和高效液相色谱法同时测定原料中甲磺酸普地诺含量的验证。
Pub Date : 2013-10-02 eCollection Date: 2013-01-01 DOI: 10.1155/2013/540676
Laura D Simionato, Leonardo Ferello, Sebastián Stamer, Patricia D Zubata, Adriana I Segall

Simple, sensitive, and economical simultaneous volumetric and HPLC methods for the determination of pridinol mesylate in raw material have been developed. The volumetric method is based on the reaction of pridinol with sodium lauryl sulphate in diluted sulphuric acid. Dimethyl yellow was used as indicator to detect the end point of the titration in aqueous/organic layer. The HPLC method for the determination of pridinol mesylate employs a reverse phase C18 column at ambient temperature with a mobile phase consisting of acetonitrile: 0.05 M potassium dihydrogen phosphate, pH adjusted to 5.0 (1 : 2, v/v). The flow rate was 0.8 mL/min. Quantitation was achieved with UV detection at 258 nm based on peak area. Both methods were found to be suitable for the quality control of pridinol mesylate in raw material.

建立了简便、灵敏、经济的同时测定原料中甲磺酸普地诺的容量法和高效液相色谱法。体积法是根据吡啶醇与硫酸十二烷基钠在稀硫酸中反应而建立的。用二甲基黄作为指示剂检测水/有机层滴定终点。采用高效液相色谱法测定甲磺酸普里地诺,色谱柱为C18反相,流动相为乙腈:0.05 M磷酸二氢钾,pH调节为5.0 (1:2,v/v)。流速0.8 mL/min。基于峰面积,采用258 nm紫外检测进行定量。两种方法均适用于甲磺酸普地诺原料的质量控制。
{"title":"Validation of simultaneous volumetric and HPLC methods for the determination of pridinol mesylate in raw material.","authors":"Laura D Simionato,&nbsp;Leonardo Ferello,&nbsp;Sebastián Stamer,&nbsp;Patricia D Zubata,&nbsp;Adriana I Segall","doi":"10.1155/2013/540676","DOIUrl":"https://doi.org/10.1155/2013/540676","url":null,"abstract":"<p><p>Simple, sensitive, and economical simultaneous volumetric and HPLC methods for the determination of pridinol mesylate in raw material have been developed. The volumetric method is based on the reaction of pridinol with sodium lauryl sulphate in diluted sulphuric acid. Dimethyl yellow was used as indicator to detect the end point of the titration in aqueous/organic layer. The HPLC method for the determination of pridinol mesylate employs a reverse phase C18 column at ambient temperature with a mobile phase consisting of acetonitrile: 0.05 M potassium dihydrogen phosphate, pH adjusted to 5.0 (1 : 2, v/v). The flow rate was 0.8 mL/min. Quantitation was achieved with UV detection at 258 nm based on peak area. Both methods were found to be suitable for the quality control of pridinol mesylate in raw material. </p>","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":"2013 ","pages":"540676"},"PeriodicalIF":0.0,"publicationDate":"2013-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/540676","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31860018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Photoinitiated polymerization of 2-hydroxyethyl methacrylate by riboflavin/triethanolamine in aqueous solution: a kinetic study. 核黄素/三乙醇胺在水溶液中光引发聚合2-甲基丙烯酸羟乙酯的动力学研究。
Pub Date : 2013-09-23 eCollection Date: 2013-01-01 DOI: 10.1155/2013/958712
Iqbal Ahmad, Kefi Iqbal, Muhammad Ali Sheraz, Sofia Ahmed, Tania Mirza, Sadia Hafeez Kazi, Mohammad Aminuddin

The polymerization of 1-3 M 2-hydroxyethyl methacrylate (HEMA) initiated by riboflavin/triethanolamine system has been studied in the pH range 6.0-9.0. An approximate measure of the kinetics of the reaction during the initial stages (~5% HEMA conversion) has been made to avoid the effect of any variations in the volume of the medium. The concentration of HEMA in polymerized solutions has been determined by a UV spectrophotometric method at 208 nm with a precision of ±3%. The initial rate of polymerization of HEMA follows apparent first-order kinetics and the rates increase with pH. This may be due to the presence of a labile proton on the hydroxyl group of HEMA. The second-order rate constants for the interaction of triethanolamine and HEMA lie in the range of 2.36 to 8.67 × 10(-2) M(-1) s(-1) at pH 6.0-9.0 suggesting an increased activity with pH. An increase in the viscosity of HEMA solutions from 1 M to 3 M leads to a decrease in the rate of polymerization probably as a result of the decrease in the reactivity of the flavin triplet state. The effect of pH and viscosity of the medium on the rate of reaction has been evaluated.

研究了核黄素/三乙醇胺体系在6.0 ~ 9.0 pH范围内引发1-3 M 2-甲基丙烯酸羟乙酯(HEMA)的聚合反应。在初始阶段(~5%的HEMA转化率),对反应动力学进行了近似测量,以避免介质体积变化的影响。采用208nm紫外分光光度法测定聚合溶液中HEMA的浓度,精密度为±3%。HEMA的初始聚合速率遵循明显的一级动力学,并且速率随ph的增加而增加。这可能是由于HEMA的羟基上存在不稳定质子。在pH 6.0 ~ 9.0时,三乙乙醇胺与HEMA反应的二级速率常数为2.36 ~ 8.67 × 10(-2) M(-1) s(-1),表明其活性随pH的增加而增加。HEMA溶液粘度从1 M增加到3 M导致聚合速率降低,这可能是由于黄素三重态反应活性降低所致。考察了pH值和介质粘度对反应速率的影响。
{"title":"Photoinitiated polymerization of 2-hydroxyethyl methacrylate by riboflavin/triethanolamine in aqueous solution: a kinetic study.","authors":"Iqbal Ahmad,&nbsp;Kefi Iqbal,&nbsp;Muhammad Ali Sheraz,&nbsp;Sofia Ahmed,&nbsp;Tania Mirza,&nbsp;Sadia Hafeez Kazi,&nbsp;Mohammad Aminuddin","doi":"10.1155/2013/958712","DOIUrl":"https://doi.org/10.1155/2013/958712","url":null,"abstract":"<p><p>The polymerization of 1-3 M 2-hydroxyethyl methacrylate (HEMA) initiated by riboflavin/triethanolamine system has been studied in the pH range 6.0-9.0. An approximate measure of the kinetics of the reaction during the initial stages (~5% HEMA conversion) has been made to avoid the effect of any variations in the volume of the medium. The concentration of HEMA in polymerized solutions has been determined by a UV spectrophotometric method at 208 nm with a precision of ±3%. The initial rate of polymerization of HEMA follows apparent first-order kinetics and the rates increase with pH. This may be due to the presence of a labile proton on the hydroxyl group of HEMA. The second-order rate constants for the interaction of triethanolamine and HEMA lie in the range of 2.36 to 8.67 × 10(-2) M(-1) s(-1) at pH 6.0-9.0 suggesting an increased activity with pH. An increase in the viscosity of HEMA solutions from 1 M to 3 M leads to a decrease in the rate of polymerization probably as a result of the decrease in the reactivity of the flavin triplet state. The effect of pH and viscosity of the medium on the rate of reaction has been evaluated. </p>","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":" ","pages":"958712"},"PeriodicalIF":0.0,"publicationDate":"2013-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/958712","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40279031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Pharmacosomes: an emerging novel vesicular drug delivery system for poorly soluble synthetic and herbal drugs. 药物小体:一种新兴的囊状药物递送系统,用于难溶性合成药物和草药。
Pub Date : 2013-09-09 DOI: 10.1155/2013/348186
Archana Pandita, Pooja Sharma

In the arena of solubility enhancement, several problems are encountered. A novel approach based on lipid drug delivery system has evolved, pharmacosomes. Pharmacosomes are colloidal, nanometric size micelles, vesicles or may be in the form of hexagonal assembly of colloidal drug dispersions attached covalently to the phospholipid. They act as befitting carrier for delivery of drugs quite precisely owing to their unique properties like small size, amphiphilicity, active drug loading, high entrapment efficiency, and stability. They help in controlled release of drug at the site of action as well as in reduction in cost of therapy, drug leakage and toxicity, increased bioavailability of poorly soluble drugs, and restorative effects. There has been advancement in the scope of this delivery system for a number of drugs used for inflammation, heart diseases, cancer, and protein delivery along with a large number of herbal drugs. Hence, pharmacosomes open new challenges and opportunities for improved novel vesicular drug delivery system.

在提高溶解度方面,遇到了几个问题。一种基于脂质给药系统的新方法——药质体已经发展起来。药物小体是胶体的,纳米大小的胶束,囊泡或可能以胶体药物分散体的六边形组装形式共价附着在磷脂上。它们具有体积小、两亲性强、载药活性强、包封效率高、稳定性好等特点,是非常合适的药物递送载体。它们有助于控制药物在作用部位的释放,降低治疗成本,药物泄漏和毒性,提高难溶性药物的生物利用度,并具有恢复作用。这种递送系统的范围已经取得了进展,用于治疗炎症、心脏病、癌症和蛋白质的递送以及大量的草药。因此,药物小体为改进新型囊泡给药系统开辟了新的挑战和机遇。
{"title":"Pharmacosomes: an emerging novel vesicular drug delivery system for poorly soluble synthetic and herbal drugs.","authors":"Archana Pandita,&nbsp;Pooja Sharma","doi":"10.1155/2013/348186","DOIUrl":"https://doi.org/10.1155/2013/348186","url":null,"abstract":"<p><p>In the arena of solubility enhancement, several problems are encountered. A novel approach based on lipid drug delivery system has evolved, pharmacosomes. Pharmacosomes are colloidal, nanometric size micelles, vesicles or may be in the form of hexagonal assembly of colloidal drug dispersions attached covalently to the phospholipid. They act as befitting carrier for delivery of drugs quite precisely owing to their unique properties like small size, amphiphilicity, active drug loading, high entrapment efficiency, and stability. They help in controlled release of drug at the site of action as well as in reduction in cost of therapy, drug leakage and toxicity, increased bioavailability of poorly soluble drugs, and restorative effects. There has been advancement in the scope of this delivery system for a number of drugs used for inflammation, heart diseases, cancer, and protein delivery along with a large number of herbal drugs. Hence, pharmacosomes open new challenges and opportunities for improved novel vesicular drug delivery system. </p>","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":"2013 ","pages":"348186"},"PeriodicalIF":0.0,"publicationDate":"2013-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/348186","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31791013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 53
Formulation Development and Evaluation of Drug Release Kinetics from Colon-Targeted Ibuprofen Tablets Based on Eudragit RL 100-Chitosan Interpolyelectrolyte Complexes. 基于苦楝酸RL - 100-壳聚糖互聚电解质配合物的结肠靶向布洛芬片处方开发及释药动力学评价。
Pub Date : 2013-08-06 eCollection Date: 2013-01-01 DOI: 10.1155/2013/838403
Kenneth Chibuzor Ofokansi, Franklin Chimaobi Kenechukwu

Colon-targeted drug delivery systems (CTDDSs) could be useful for local treatment of inflammatory bowel diseases (IBDs). In this study, various interpolyelectrolyte complexes (IPECs), formed between Eudragit RL100 (EL) and chitosan (CS), by nonstoichiometric method, and tablets based on the IPECs, prepared by wet granulation, were evaluated as potential oral CTDDSs for ibuprofen (IBF). Results obtained showed that the tablets conformed to compendial requirements for acceptance and that CS and EL formed IPECs that showed pH-dependent swelling properties and prolonged the in vitro release of IBF from the tablets in the following descending order: 3 : 2 > 2 : 3 > 1 : 1 ratios of CS and EL. An electrostatic interaction between the carbonyl (-CO-) group of EL and amino (-NH3 (+)) group of CS of the tablets formulated with the IPECs was capable of preventing drug release in the stomach and small intestine and helped in delivering the drug to the colon. Kinetic analysis of drug release profiles showed that the systems predominantly released IBF in a zero-order manner. IPECs based on CS and EL could be exploited successfully for colon-targeted delivery of IBF in the treatment of IBDs.

结肠靶向给药系统(CTDDSs)可用于局部治疗炎症性肠病(IBDs)。本研究采用非化学计量法,对乌龙茶RL100 (EL)与壳聚糖(CS)形成的多种聚电解质间络合物(ipec)和湿造粒法制备的ipec片作为布洛芬(IBF)的潜在口服ctdds进行了评价。结果表明,该片剂符合药典验收要求,且CS与EL形成的ipec具有ph依赖性的溶胀特性,其体外释放时间由大到小依次为:CS与EL的比例为3:2 > 2:3 > 1:1。与ipec配制的片剂中EL的羰基(- co -)基团与CS的氨基(- nh3(+))基团之间的静电相互作用能够阻止药物在胃和小肠中的释放,并有助于将药物输送到结肠。药物释放动力学分析表明,该系统主要以零级方式释放IBF。基于CS和EL的ipec可以成功地用于ibd治疗中IBF的结肠靶向递送。
{"title":"Formulation Development and Evaluation of Drug Release Kinetics from Colon-Targeted Ibuprofen Tablets Based on Eudragit RL 100-Chitosan Interpolyelectrolyte Complexes.","authors":"Kenneth Chibuzor Ofokansi,&nbsp;Franklin Chimaobi Kenechukwu","doi":"10.1155/2013/838403","DOIUrl":"https://doi.org/10.1155/2013/838403","url":null,"abstract":"<p><p>Colon-targeted drug delivery systems (CTDDSs) could be useful for local treatment of inflammatory bowel diseases (IBDs). In this study, various interpolyelectrolyte complexes (IPECs), formed between Eudragit RL100 (EL) and chitosan (CS), by nonstoichiometric method, and tablets based on the IPECs, prepared by wet granulation, were evaluated as potential oral CTDDSs for ibuprofen (IBF). Results obtained showed that the tablets conformed to compendial requirements for acceptance and that CS and EL formed IPECs that showed pH-dependent swelling properties and prolonged the in vitro release of IBF from the tablets in the following descending order: 3 : 2 > 2 : 3 > 1 : 1 ratios of CS and EL. An electrostatic interaction between the carbonyl (-CO-) group of EL and amino (-NH3 (+)) group of CS of the tablets formulated with the IPECs was capable of preventing drug release in the stomach and small intestine and helped in delivering the drug to the colon. Kinetic analysis of drug release profiles showed that the systems predominantly released IBF in a zero-order manner. IPECs based on CS and EL could be exploited successfully for colon-targeted delivery of IBF in the treatment of IBDs. </p>","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":"2013 ","pages":"838403"},"PeriodicalIF":0.0,"publicationDate":"2013-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/838403","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31692819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 32
Nontargeted Identification of the Phenolic and Other Compounds of Saraca asoca by High Performance Liquid Chromatography-Positive Electrospray Ionization and Quadrupole Time-of-Flight Mass Spectrometry. 高效液相色谱-正电喷雾电离和四极杆飞行时间质谱法非靶向鉴定水芹中酚类和其他化合物。
Pub Date : 2013-08-05 eCollection Date: 2013-01-01 DOI: 10.1155/2013/293935
Ashwani Mittal, Preeti Kadyan, Anjum Gahlaut, Rajesh Dabur

High performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometer was used for separation and identification of phenolic and other compounds in the water extracts of Saraca asoca (Roxb.), De. Wilde. The aim of the study was to identify and evaluate the distribution of phenolic compounds in the different parts of the plant. The identity of compounds was established through the comparison with standards and characteristic base peaks as well as other daughter ions. In crude extracts, 34 catechin derivatives, 34 flavonoids, and 17 other compounds were identified. Interestingly, further analysis of compounds showed plant part specific unique pattern of metabolites; that is, regenerated bark is observed to be the best source for catechin/catechin derivative while flowers were found to be the source for wide variety of flavonoids. Moreover, these plant part specific compounds can be used as biomarkers for the identification of plant material or herbal drugs. Overall, the present study provides for the first time a comprehensive analysis of the phenolic components of this herb which may be helpful not only to understand their usage but also to contribute to quality control as well.

采用高效液相色谱-四极杆飞行时间质谱联用技术,对菝葜(Roxb.), De. Wilde水提物中的酚类化合物进行了分离鉴定。本研究的目的是鉴定和评价酚类化合物在植物不同部位的分布。通过与标准峰、特征碱峰及其它子离子的比较,确定了化合物的性质。在粗提取物中鉴定出34种儿茶素衍生物、34种黄酮类化合物和17种其他化合物。有趣的是,进一步分析化合物显示出植物部分特定的独特代谢物模式;也就是说,再生树皮是儿茶素/儿茶素衍生物的最佳来源,而花被发现是多种黄酮类化合物的来源。此外,这些植物部位特异性化合物可作为植物材料或中草药鉴定的生物标志物。本研究首次对其酚类成分进行了全面分析,不仅有助于了解其用途,而且有助于其质量控制。
{"title":"Nontargeted Identification of the Phenolic and Other Compounds of Saraca asoca by High Performance Liquid Chromatography-Positive Electrospray Ionization and Quadrupole Time-of-Flight Mass Spectrometry.","authors":"Ashwani Mittal,&nbsp;Preeti Kadyan,&nbsp;Anjum Gahlaut,&nbsp;Rajesh Dabur","doi":"10.1155/2013/293935","DOIUrl":"https://doi.org/10.1155/2013/293935","url":null,"abstract":"<p><p>High performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometer was used for separation and identification of phenolic and other compounds in the water extracts of Saraca asoca (Roxb.), De. Wilde. The aim of the study was to identify and evaluate the distribution of phenolic compounds in the different parts of the plant. The identity of compounds was established through the comparison with standards and characteristic base peaks as well as other daughter ions. In crude extracts, 34 catechin derivatives, 34 flavonoids, and 17 other compounds were identified. Interestingly, further analysis of compounds showed plant part specific unique pattern of metabolites; that is, regenerated bark is observed to be the best source for catechin/catechin derivative while flowers were found to be the source for wide variety of flavonoids. Moreover, these plant part specific compounds can be used as biomarkers for the identification of plant material or herbal drugs. Overall, the present study provides for the first time a comprehensive analysis of the phenolic components of this herb which may be helpful not only to understand their usage but also to contribute to quality control as well. </p>","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":"2013 ","pages":"293935"},"PeriodicalIF":0.0,"publicationDate":"2013-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/293935","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31692818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 27
Comparison of various generations of superporous hydrogels based on chitosan-acrylamide and in vitro drug release. 不同代壳聚糖丙烯酰胺基超孔水凝胶的体外释药比较。
Pub Date : 2013-07-29 eCollection Date: 2013-01-01 DOI: 10.1155/2013/624841
Shikha Bhalla, Manju Nagpal

The aim of the current research work was to prepare and evaluate different generations of superporous hydrogels (SPH) of acrylamide and chitosan using gas blowing technique and evaluate them for swelling, mechanical properties, FTIR, SEM, XRD, and in vitro drug release. The ingredients used were acrylamide, N,N'-methylene bisacrylamide, chitosan, Pluronic F127, ammonium per sulfate-N,N,N',N'-tetramethylenediamine, and sodium bicarbonate. All ingredients were mixed sequentially with thorough stirring. The effect of different drying conditions on properties of SPH was also evaluated. Ethanol treated batched showed maximum swelling properties due to uniform pores as indicated in SEM studies. Equilibrium swelling time was less than 10 min in all batches. Freeze drying led to lowering of density which is also supported by porosity and void fraction data. Maximum mechanical strength was found in superporous hydrogel interpenetrating networks due to crosslinked polymeric network. 70% drug was released at the end of 2 h, and further the release was sustained till the end of 24 h. In vitro drug release kinetics showed that drug release occurs by diffusion and follows Super Case II transport indicating that mechanism of drug release is not clear. Superporous hydrogel interpenetrating networks can be successfully used as sustained release gastroretentive devices.

本研究的目的是利用气吹法制备和评价不同代丙烯酰胺和壳聚糖的超孔水凝胶(SPH),并对其溶胀、力学性能、FTIR、SEM、XRD和体外释药性能进行评价。所用原料为丙烯酰胺、N,N'-亚甲基双丙烯酰胺、壳聚糖、Pluronic F127、硫酸铵-N,N,N',N'-四亚甲二胺、碳酸氢钠。所有的配料依次搅拌均匀。研究了不同干燥条件对SPH性能的影响。扫描电镜研究表明,乙醇处理的批料由于均匀的孔隙而表现出最大的膨胀特性。所有批次的平衡膨胀时间均小于10 min。冻干导致密度降低,孔隙率和空隙率数据也证实了这一点。由于交联聚合物网络的存在,超多孔水凝胶互穿网络具有最大的机械强度。2 h后释放70%,24 h后持续释放。体外药物释放动力学表明,药物通过扩散释放,并遵循Super Case II转运,药物释放机制尚不清楚。超多孔水凝胶互穿网络可以成功地作为缓释胃保留装置。
{"title":"Comparison of various generations of superporous hydrogels based on chitosan-acrylamide and in vitro drug release.","authors":"Shikha Bhalla,&nbsp;Manju Nagpal","doi":"10.1155/2013/624841","DOIUrl":"https://doi.org/10.1155/2013/624841","url":null,"abstract":"<p><p>The aim of the current research work was to prepare and evaluate different generations of superporous hydrogels (SPH) of acrylamide and chitosan using gas blowing technique and evaluate them for swelling, mechanical properties, FTIR, SEM, XRD, and in vitro drug release. The ingredients used were acrylamide, N,N'-methylene bisacrylamide, chitosan, Pluronic F127, ammonium per sulfate-N,N,N',N'-tetramethylenediamine, and sodium bicarbonate. All ingredients were mixed sequentially with thorough stirring. The effect of different drying conditions on properties of SPH was also evaluated. Ethanol treated batched showed maximum swelling properties due to uniform pores as indicated in SEM studies. Equilibrium swelling time was less than 10 min in all batches. Freeze drying led to lowering of density which is also supported by porosity and void fraction data. Maximum mechanical strength was found in superporous hydrogel interpenetrating networks due to crosslinked polymeric network. 70% drug was released at the end of 2 h, and further the release was sustained till the end of 24 h. In vitro drug release kinetics showed that drug release occurs by diffusion and follows Super Case II transport indicating that mechanism of drug release is not clear. Superporous hydrogel interpenetrating networks can be successfully used as sustained release gastroretentive devices. </p>","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":"2013 ","pages":"624841"},"PeriodicalIF":0.0,"publicationDate":"2013-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/624841","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31690584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 21
Formulation development and evaluation of fast disintegrating tablets of salbutamol sulphate for respiratory disorders. 呼吸系统疾病用硫酸沙丁胺醇快速崩解片的处方研制与评价。
Pub Date : 2013-07-15 eCollection Date: 2013-01-01 DOI: 10.1155/2013/674507
Deepak Sharma

Recent developments in fast disintegrating tablets have brought convenience in dosing to pediatric and elderly patients who have trouble in swallowing tablets. The objective of the present study was to prepare the fast disintegrating tablet of salbutamol sulphate for respiratory disorders for pediatrics. As precision of dosing and patient's compliance become important prerequisites for a long-term treatment, there is a need to develop a formulation for this drug which overcomes problems such as difficulty in swallowing, inconvenience in administration while travelling, and patient's acceptability. Hence, the present investigation were undertaken with a view to develop a fast disintegrating tablet of salbutamol sulphate which offers a new range of products having desired characteristics and intended benefits. Superdisintegrants such as sodium starch glycolate was optimized. Different binders were optimized along with optimized superdisintegrant concentration. The tablets were prepared by direct compression technique. The tablets were evaluated for hardness, friability, weight variation, wetting time, disintegration time, and uniformity of content. Optimized formulation was evaluated by in vitro dissolution test, drug-excipient compatibility, and accelerated stability study. It was concluded that fast disintegrating tablets of salbutamol sulphate were formulated successfully with desired characteristics which disintegrated rapidly; provided rapid onset of action; and enhanced the patient convenience and compliance.

快速崩解片剂的最新发展为吞咽片剂有困难的儿科和老年患者提供了给药方便。本研究的目的是制备用于儿科呼吸系统疾病的硫酸沙丁胺醇快速崩解片。由于剂量的准确性和患者的依从性成为长期治疗的重要先决条件,因此需要开发一种药物配方,以克服诸如吞咽困难,旅行时给药不方便以及患者的可接受性等问题。因此,本研究旨在开发一种快速崩解的硫酸沙丁胺醇片剂,以提供一系列具有期望特性和预期效益的新产品。对乙醇酸淀粉钠等强力崩解剂进行了优化。对不同粘结剂进行了优化,并确定了最佳超崩解剂浓度。采用直接压片法制备。对其硬度、脆性、重量变化、润湿时间、崩解时间和含量均匀性进行了评价。通过体外溶出度试验、药物与赋形剂相容性及加速稳定性研究对优化后的配方进行评价。结果表明:研制成功的硫酸沙丁胺醇快崩解片具有崩解快的特点;提供迅速的行动;提高了患者的便利性和依从性。
{"title":"Formulation development and evaluation of fast disintegrating tablets of salbutamol sulphate for respiratory disorders.","authors":"Deepak Sharma","doi":"10.1155/2013/674507","DOIUrl":"https://doi.org/10.1155/2013/674507","url":null,"abstract":"<p><p>Recent developments in fast disintegrating tablets have brought convenience in dosing to pediatric and elderly patients who have trouble in swallowing tablets. The objective of the present study was to prepare the fast disintegrating tablet of salbutamol sulphate for respiratory disorders for pediatrics. As precision of dosing and patient's compliance become important prerequisites for a long-term treatment, there is a need to develop a formulation for this drug which overcomes problems such as difficulty in swallowing, inconvenience in administration while travelling, and patient's acceptability. Hence, the present investigation were undertaken with a view to develop a fast disintegrating tablet of salbutamol sulphate which offers a new range of products having desired characteristics and intended benefits. Superdisintegrants such as sodium starch glycolate was optimized. Different binders were optimized along with optimized superdisintegrant concentration. The tablets were prepared by direct compression technique. The tablets were evaluated for hardness, friability, weight variation, wetting time, disintegration time, and uniformity of content. Optimized formulation was evaluated by in vitro dissolution test, drug-excipient compatibility, and accelerated stability study. It was concluded that fast disintegrating tablets of salbutamol sulphate were formulated successfully with desired characteristics which disintegrated rapidly; provided rapid onset of action; and enhanced the patient convenience and compliance. </p>","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":"2013 ","pages":"674507"},"PeriodicalIF":0.0,"publicationDate":"2013-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/674507","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31667659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 64
Suitability of Biomorphic Silicon Carbide Ceramics as Drug Delivery Systems against Bacterial Biofilms. 生物形态碳化硅陶瓷作为抗细菌生物膜药物传递系统的适用性。
Pub Date : 2013-07-07 Print Date: 2013-01-01 DOI: 10.1155/2013/104529
P Díaz-Rodríguez, A Pérez-Estévez, R Seoane, P González, J Serra, M Landin

The present work is aimed at getting a new insight into biomorphic silicon carbides (bioSiCs) as bone replacement materials. BioSiCs from a variety of precursors were produced, characterized, and loaded with a broad-spectrum antibiotic. The capacity of loaded bioSiCs for preventing and/or treating preformed S. aureus biofilms has been studied. The differences in precursor characteristics are maintained after the ceramic production process. All bioSiCs allow the loading process by capillarity, giving loaded materials with drug release profiles dependent on their microstructure. The amount of antibiotic released in liquid medium during the first six hours depends on bioSiC porosity, but it could exceed the minimum inhibitory concentration of Staphylococcus aureus, for all the materials studied, thus preventing the proliferation of bacteria. Differences in the external surface and the number and size of open external pores of bioSiCs contribute towards the variations in the effect against bacteria when experiments are carried out using solid media. The internal structure and surface properties of all the systems seem to facilitate the therapeutic activity of the antibiotic on the preformed biofilms, reducing the number of viable bacteria present in the biofilm compared to controls.

目前的工作旨在对生物形态碳化硅(bioSiCs)作为骨替代材料有一个新的认识。从各种前体中制备生物制剂,对其进行了表征,并装载了广谱抗生素。已经研究了负载生物硅对预成型金黄色葡萄球菌生物膜的预防和/或处理能力。在陶瓷生产过程中,前驱体特性的差异保持不变。所有的生物材料都允许通过毛细作用加载过程,使加载材料具有取决于其微观结构的药物释放谱。在前6小时内,抗生素在液体介质中的释放量取决于生物碳化硅的孔隙度,但对于所有研究的材料,它可能超过金黄色葡萄球菌的最低抑制浓度,从而阻止细菌的增殖。当使用固体介质进行实验时,生物硅的外表面以及开放的外孔的数量和大小的差异导致了对细菌效果的变化。所有系统的内部结构和表面特性似乎都促进了抗生素对预成型生物膜的治疗活性,与对照相比,减少了生物膜中存在的活菌数量。
{"title":"Suitability of Biomorphic Silicon Carbide Ceramics as Drug Delivery Systems against Bacterial Biofilms.","authors":"P Díaz-Rodríguez,&nbsp;A Pérez-Estévez,&nbsp;R Seoane,&nbsp;P González,&nbsp;J Serra,&nbsp;M Landin","doi":"10.1155/2013/104529","DOIUrl":"https://doi.org/10.1155/2013/104529","url":null,"abstract":"<p><p>The present work is aimed at getting a new insight into biomorphic silicon carbides (bioSiCs) as bone replacement materials. BioSiCs from a variety of precursors were produced, characterized, and loaded with a broad-spectrum antibiotic. The capacity of loaded bioSiCs for preventing and/or treating preformed S. aureus biofilms has been studied. The differences in precursor characteristics are maintained after the ceramic production process. All bioSiCs allow the loading process by capillarity, giving loaded materials with drug release profiles dependent on their microstructure. The amount of antibiotic released in liquid medium during the first six hours depends on bioSiC porosity, but it could exceed the minimum inhibitory concentration of Staphylococcus aureus, for all the materials studied, thus preventing the proliferation of bacteria. Differences in the external surface and the number and size of open external pores of bioSiCs contribute towards the variations in the effect against bacteria when experiments are carried out using solid media. The internal structure and surface properties of all the systems seem to facilitate the therapeutic activity of the antibiotic on the preformed biofilms, reducing the number of viable bacteria present in the biofilm compared to controls. </p>","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":"2013 ","pages":"104529"},"PeriodicalIF":0.0,"publicationDate":"2013-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/104529","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31649869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Microemulsion: new insights into the ocular drug delivery. 微乳剂:眼部给药的新视角。
Pub Date : 2013-06-27 Print Date: 2013-01-01 DOI: 10.1155/2013/826798
Rahul Rama Hegde, Anurag Verma, Amitava Ghosh

Delivery of drugs into eyes using conventional drug delivery systems, such as solutions, is a considerable challenge to the treatment of ocular diseases. Drug loss from the ocular surface by lachrymal fluid secretion, lachrymal fluid-eye barriers, and blood-ocular barriers are main obstacles. A number of ophthalmic drug delivery carriers have been made to improve the bioavailability and to prolong the residence time of drugs applied topically onto the eye. The potential use of microemulsions as an ocular drug delivery carrier offers several favorable pharmaceutical and biopharmaceutical properties such as their excellent thermodynamic stability, phase transition to liquid-crystal state, very low surface tension, and small droplet size, which may result in improved ocular drug retention, extended duration of action, high ocular absorption, and permeation of loaded drugs. Further, both lipophilic and hydrophilic characteristics are present in microemulsions, so that the loaded drugs can diffuse passively as well get significantly partitioned in the variable lipophilic-hydrophilic corneal barrier. This review will provide an insight into previous studies on microemulsions for ocular delivery of drugs using various nonionic surfactants, cosurfactants, and associated irritation potential on the ocular surface. The reported in vivo experiments have shown a delayed effect of drug incorporated in microemulsion and an increase in the corneal permeation of the drug.

使用溶液等传统给药系统将药物送入眼内是治疗眼部疾病的一大挑战。泪液分泌、泪液-眼屏障和血液-眼屏障是药物从眼表流失的主要障碍。为了提高局部用药在眼部的生物利用度和延长药物在眼部的停留时间,人们制造了许多眼科给药载体。微乳剂可用作眼部给药载体,具有多种有利的制药和生物制药特性,如其出色的热力学稳定性、向液晶状态的相变、极低的表面张力和较小的液滴尺寸,可改善眼部药物滞留、延长作用时间、促进眼部吸收和药物渗透。此外,微乳剂同时具有亲脂性和亲水性的特点,因此所含药物既能被动扩散,又能在亲脂性-亲水性可变的角膜屏障中显著分区。本综述将深入探讨以往使用各种非离子表面活性剂、助表面活性剂进行眼部给药的微乳剂研究,以及这些微乳剂对眼表的潜在刺激性。所报告的体内实验表明,微乳剂中的药物具有延迟作用,并能增加药物在角膜上的渗透。
{"title":"Microemulsion: new insights into the ocular drug delivery.","authors":"Rahul Rama Hegde, Anurag Verma, Amitava Ghosh","doi":"10.1155/2013/826798","DOIUrl":"10.1155/2013/826798","url":null,"abstract":"<p><p>Delivery of drugs into eyes using conventional drug delivery systems, such as solutions, is a considerable challenge to the treatment of ocular diseases. Drug loss from the ocular surface by lachrymal fluid secretion, lachrymal fluid-eye barriers, and blood-ocular barriers are main obstacles. A number of ophthalmic drug delivery carriers have been made to improve the bioavailability and to prolong the residence time of drugs applied topically onto the eye. The potential use of microemulsions as an ocular drug delivery carrier offers several favorable pharmaceutical and biopharmaceutical properties such as their excellent thermodynamic stability, phase transition to liquid-crystal state, very low surface tension, and small droplet size, which may result in improved ocular drug retention, extended duration of action, high ocular absorption, and permeation of loaded drugs. Further, both lipophilic and hydrophilic characteristics are present in microemulsions, so that the loaded drugs can diffuse passively as well get significantly partitioned in the variable lipophilic-hydrophilic corneal barrier. This review will provide an insight into previous studies on microemulsions for ocular delivery of drugs using various nonionic surfactants, cosurfactants, and associated irritation potential on the ocular surface. The reported in vivo experiments have shown a delayed effect of drug incorporated in microemulsion and an increase in the corneal permeation of the drug. </p>","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":"2013 ","pages":"826798"},"PeriodicalIF":0.0,"publicationDate":"2013-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712243/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31649871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stability of betaine capsules. 甜菜碱胶囊的稳定性。
Pub Date : 2013-06-03 Print Date: 2013-01-01 DOI: 10.1155/2013/458625
Mirza Akram Hossain, Stéphanie Boily, Natasha Beauregard, Jean-Marc Forest, Grégoire Leclair
Betaine is used to treat homocystinuria and is not available in Canada as a formulated drug. In order to facilitate the administration of this compound to patients, a capsule formulation and an evaluation of its stability were required. Capsule formulations of betaine were developed (160 mg and 625 mg of betaine per capsule). As betaine has no chromophore, an HPLC-ELSD analytical method was also developed. The critical quality attributes of these formulations were evaluated (content assay, content uniformity, and dissolution) as well as their stability. Capsules with acceptable quality attributes were produced. These capsules remained stable for 1 year when stored in airtight containers at controlled room temperature. However, shelf life decreased dramatically in nonairtight containers at 30°C (3 months for the lactose-containing capsules of 160 mg and 6 months for the capsules of 625 mg).
甜菜碱用于治疗同型半胱氨酸尿,在加拿大不能作为配方药物使用。为了方便患者给药,需要胶囊配方和稳定性评估。开发了甜菜碱胶囊制剂(每粒胶囊含有160毫克和625毫克甜菜碱)。由于甜菜碱不含发色团,因此建立了HPLC-ELSD分析方法。评估了这些制剂的关键质量属性(含量测定、含量均匀性和溶出度)及其稳定性。生产的胶囊具有可接受的质量属性。这些胶囊保存在密闭的容器中,在室温下保持稳定1年。然而,在30°C的非密闭容器中,保质期急剧缩短(含乳糖胶囊为160毫克为3个月,含乳糖胶囊为625毫克为6个月)。
{"title":"Stability of betaine capsules.","authors":"Mirza Akram Hossain,&nbsp;Stéphanie Boily,&nbsp;Natasha Beauregard,&nbsp;Jean-Marc Forest,&nbsp;Grégoire Leclair","doi":"10.1155/2013/458625","DOIUrl":"https://doi.org/10.1155/2013/458625","url":null,"abstract":"Betaine is used to treat homocystinuria and is not available in Canada as a formulated drug. In order to facilitate the administration of this compound to patients, a capsule formulation and an evaluation of its stability were required. Capsule formulations of betaine were developed (160 mg and 625 mg of betaine per capsule). As betaine has no chromophore, an HPLC-ELSD analytical method was also developed. The critical quality attributes of these formulations were evaluated (content assay, content uniformity, and dissolution) as well as their stability. Capsules with acceptable quality attributes were produced. These capsules remained stable for 1 year when stored in airtight containers at controlled room temperature. However, shelf life decreased dramatically in nonairtight containers at 30°C (3 months for the lactose-containing capsules of 160 mg and 6 months for the capsules of 625 mg).","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":"2013 ","pages":"458625"},"PeriodicalIF":0.0,"publicationDate":"2013-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/458625","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31586302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
ISRN Pharmaceutics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1